由生成式人工智能驱动的生物医药科技公司英硅智能近期与全球头部跨国药企礼来达成药物研发战略合作。双方将充分发挥英硅智能自主研发的AI制药平台Pharma.AI的前沿技术优势,结合礼来在药物开发及疾病研究领域的深厚积淀,共同加速创新疗法的发现与开发。
由生成式人工智能驱动的生物医药科技公司英硅智能近期与全球头部跨国药企礼来达成药物研发战略合作。双方将充分发挥英硅智能自主研发的AI制药平台Pharma.AI的前沿技术优势,结合礼来在药物开发及疾病研究领域的深厚积淀,共同加速创新疗法的发现与开发。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.